Retour aux projets

19305.1 PFLS-LS

Investigation of in vitro response of human blood to Qvanteq's anti-thrombotic and pro-healing surface technology applied on vascular stents

Résumé

Investigation of in vitro response of human blood to Qvanteq's anti-thrombotic and pro-healing surface technology applied on vascular stents

Textes supplémentaires

Abstract

Qvanteq AG (Zurich, Switzerland; ETH Spinoff) has developped a proprietary coating-free surface technology for vascular stents (small metal mesh tubes, implanted into blood vessels to restore blood flow). The anti-thrombotic properties of a surface-treated stent promisses clinical advantages for patients and healthcare payers as it potentially reduces magnitude and duration of post-intervention anti-coagulant drug therapies and cumbersome re-interventions

Participants

Arik Zucker

Wirtschaftspartner

arik.zucker@qvanteq.com

Qvanteq AG Arik Zucker Technoparkstrasse 1 8005 Zürich ZH CH

Martin Ehrbar

Kontaktperson

martin.ehrbar@usz.ch

USZ Universitätsspital Zürich Martin Ehrbar Schmelzbergstrasse 12 8091 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2016-07-31
Date de fin
2018-04-30
Coûts totaux approuvés
CHF 295638.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T115 Medical technology 100.0%